Wellington Management Group
CCXI

Wellington Management Group’s ChemoCentryx, Inc. CCXI Stock Holding History

Wellington Management Group’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-248,943
Closed -$12.9M – 2190
2022
Q3 		$12.9M Sell
248,943
-332,107
-57% -$13.7M ﹤0.01% 1033
2022
Q2 		$14.4M Sell
581,050
-64,783
-10% -$1.43M ﹤0.01% 1032
2022
Q1 		$16.2M Buy
645,833
+157,924
+32% +$4.44M ﹤0.01% 1068
2021
Q4 		$17.8M Buy
+487,909
New +$17.1M ﹤0.01% 1110
2021
Q2 		– Sell
-6,111,277
Closed -$313M – 2332
2021
Q1 		$313M Sell
6,111,277
-37,402
-0.6% -$2.25M 0.06% 323
2020
Q4 		$381M Sell
6,148,679
-554,655
-8% -$31.8M 0.07% 263
2020
Q3 		$367M Buy
6,703,334
+1,906,163
+40% +$103M 0.08% 235
2020
Q2 		$276M Buy
+4,797,171
New +$261M 0.06% 270
2018
Q4 		– Sell
-32,813
Closed -$414K – 2248
2018
Q3 		$414K Hold
32,813
– – ﹤0.01% 2085
2018
Q2 		$432K Buy
+32,813
New +$392K ﹤0.01% 2082
2013
Q3 		– Sell
-186,800
Closed -$2.64M – 2250
2013
Q2 		$2.64M Buy
+186,800
New +$2.42M ﹤0.01% 1579

Other funds holding CCXI

HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Wellington Management Group's CCXI Position: Q4 2022 in Review

Wellington Management Group sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 248,943 shares — an estimated $12.9M sold.

Wellington Management Group first reported a position in CCXI in Q2 2013 and held it in 11 quarters. The position peaked at $381M in Q4 2020. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

  • Wellington Management Group reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
  • Wellington Management Group sold 248,943 ChemoCentryx, Inc. shares in Q4 2022, an estimated $12.9M.
  • Wellington Management Group first reported a position in ChemoCentryx, Inc. in Q2 2013 and held it in 11 quarters.
  • Wellington Management Group's ChemoCentryx, Inc. position peaked at $381M in Q4 2020.
  • 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Wellington Management Group's 13F filing for Q4 2022, filed 13 Feb 2023.